...
首页> 外文期刊>Glia >A Proinvasive Role for the Ca~(2+)-Activated K~+ Channel KCa3.1 in Malignant Glioma
【24h】

A Proinvasive Role for the Ca~(2+)-Activated K~+ Channel KCa3.1 in Malignant Glioma

机译:Ca〜(2+)激活的K〜+通道KCa3.1在恶性胶质瘤中的侵袭性作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Glioblastoma multiforme are highly motile primary brain tumors. Diffuse tissue invasion hampers surgical resection leading to poor patient prognosis. Recent studies suggest that intracellular Ca~(2+) acts as a master regulator for cell motility and engages a number of downstream signals including Ca~(2+)-activated ion channels. Querying the REepository of Molecular BRAin Neoplasia DaTa (REMBRANDT), an annotated patient gene database maintained by the National Cancer Institute, we identified the intermediate conductance Ca~(2+)-activated K~+ channels, KCa3.1, being overexpressed in 32% of glioma patients where protein expression significantly correlated with poor patient survival. To mechanistically link KCa3.1 expression to glioma invasion, we selected patient gliomas that, when propagated as xenolines in vivo, present with either high or low KCa3.1 expression. In addition, we generated U251 glioma cells that stably express an inducible knockdown shRNA to experimentally eliminate KCa3.1 expression. Subjecting these cells to a combination of in vitro and in situ invasion assays, we demonstrate that KCa3.1 expression significantly enhances glioma invasion and that either specific pharmacological inhibition with TRAM- 34 or elimination of the channel impairs invasion. Importantly, after intracranial implantation into SCID mice, ablation of KCa3.1 with inducible shRNA resulted in a significant reduction in tumor invasion into surrounding brain in vivo. These results show that KCa3.1 confers an invasive phenotype that significantly worsens a patient’s outlook, and suggests that KCa3.1 represents a viable therapeutic target to reduce glioma invasion.
机译:多形性胶质母细胞瘤是高度运动的原发性脑肿瘤。弥漫性组织浸润妨碍手术切除,导致患者预后不良。最近的研究表明,细胞内Ca〜(2+)充当细胞运动的主要调节剂,并参与包括Ca〜(2+)激活的离子通道在内的许多下游信号。查询由国家癌症研究所维护的带注释的患者基因数据库分子BRAin瘤形成DaTa(REMBRANDT)的存储库,我们确定了中间电导Ca〜(2+)激活的K〜+通道KCa3.1在32个细胞中过表达蛋白质表达与不良患者生存率显着相关的神经胶质瘤患者百分比。为了将KCa3.1表达与神经胶质瘤浸润机械地联系起来,我们选择了患者神经胶质瘤,当它们以异种素形式在体内传播时,呈现出高或低的KCa3.1表达。此外,我们生成了U251胶质瘤细胞,该细胞稳定表达诱导型敲除shRNA,以实验方式消除KCa3.1表达。使这些细胞接受体外和原位侵袭试验的组合,我们证明KCa3.1表达显着增强神经胶质瘤侵袭,或者用TRAM-34进行特异性药理抑制或消除通道损害侵袭。重要的是,在颅内植入SCID小鼠后,用诱导型shRNA消融KCa3.1可显着减少体内肿瘤侵袭周围脑的能力。这些结果表明,KCa3.1具有侵袭性表型,可显着恶化患者的视力,并表明KCa3.1是减少神经胶质瘤侵袭的可行治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号